1800010I international aids vaccine initiative manufacture of human flu challenge material
Active Awarded Last action
- Contract number
- 75N93018F00002
- Awardee
-
International Aids Vaccine Initiative Inc. UEI ZEJBC8JQM3P5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,151,337
Award facts
- Opportunity
-
- RFPDMIDNIAIDNIHAI2017089 Solicitation number
- Contract value 16% obligated
-
- $4,151,337.00 Current, with exercised options
- $26,065,720.00 Potential, with all options
- Completion date 84% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- New York, NY 10004, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $89,031 | |
| Funding Only Action | -$3,351 | |
| Supplemental Agreement for work within scope | $136,951 | |
| Funding Only Action | -$175,714 | |
| Funding Only Action | $96,744 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $1,217,730 | |
| Original award | $2,789,946 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to International AIDS Vaccine Initiative Inc. on August 28, 2018, with a ceiling value of $26.065 million for manufacture of human flu challenge material.
Work is performed in New York, NY under Cost Plus Fixed Fee pricing, with an ultimate completion date of May 14, 2028. The delivery order supports IAVI's vaccine development and manufacturing services, including process development, analytical testing, cGMP manufacturing, and regulatory support for vaccine candidates advancing toward clinical trials.
Quick answers
Who was awarded contract 75N93018F00002?
75N93018F00002 was awarded to International Aids Vaccine Initiative Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 28, 2018.
How much is contract 75N93018F00002 worth?
The government has obligated $4,151,337 on 75N93018F00002. Its potential value, with all options, is $26,065,720.
Is contract 75N93018F00002 an order under another contract?
Yes. 75N93018F00002 is a delivery order under 75N93018D00010, an indefinite delivery contract.
Was contract 75N93018F00002 competed?
The extent of competition for 75N93018F00002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award